Search research articles
Contact Us
Filters
Showing results (21-30 of 90) with videos related to
Page
of 9
Sort By:
Haematologica
|
January 1, 1990
Heterogeneity of circulating hematopoietic progenitors in cancer patients treated with high-dose cyclophosphamide and recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF)
S Siena, M Bregni, F Ravagnani, et al.
The Journal of Experimental Medicine
|
November 1, 1989
Ras oncogene mutation in multiple myeloma
A Neri, J P Murphy, L Cro, et al.
Blood
|
January 15, 1997
Molecular monitoring of minimal residual disease in follicular and mantle cell non-Hodgkin's lymphomas treated with high-dose chemotherapy and peripheral blood progenitor cell autografting
P Corradini, M Astolfi, C Cherasco, et al.
Lancet (London, England)
|
September 9, 1989
Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation
A M Gianni, S Siena, M Bregni, et al.
Leukemia Research
|
January 1, 1990
Establishment from an adult leukemic patient of two novel precursor B cell lines with different growth modality
C Tarella, P Pregno, E Gallo, et al.
Bone Marrow Transplantation
|
August 1, 1997
Analysis of the immunoglobulin heavy-chain gene rearrangement providing molecular evidence of second lymphoma in a patient in apparent relapse after autotransplantation
S Campana, P Corradini, M Astolfi, et al.
Bone Marrow Transplantation
|
June 1, 2011
Proposed definition of 'poor mobilizer' in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo ItalianoTrapianto di Midollo Osseo
A Olivieri, M Marchetti, R Lemoli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1995
Haematological support of high-dose sequential chemotherapy: clinical evidence for reduction of toxicity and high response rates in poor risk lymphomas
C Tarella, P Gavarotti, D Caracciolo, et al.
Leukemia & Lymphoma
|
June 28, 2001
Central nervous system relapse in a patient with mantle cell lymphoma in continuous clinical and molecular remission at six years since autografting
M Ladetto, S Sametti, M Astolfi, et al.
Haematologica
|
January 1, 1990
Conditions influencing the expansion of the circulating hemopoietic progenitor cell compartment
C Tarella, D Ferrero, S Siena, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 90) with videos related to
Sort By:
Page
of 9
Haematologica
|
January 1, 1990
Heterogeneity of circulating hematopoietic progenitors in cancer patients treated with high-dose cyclophosphamide and recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF)
S Siena, M Bregni, F Ravagnani, et al.
The Journal of Experimental Medicine
|
November 1, 1989
Ras oncogene mutation in multiple myeloma
A Neri, J P Murphy, L Cro, et al.
Blood
|
January 15, 1997
Molecular monitoring of minimal residual disease in follicular and mantle cell non-Hodgkin's lymphomas treated with high-dose chemotherapy and peripheral blood progenitor cell autografting
P Corradini, M Astolfi, C Cherasco, et al.
Lancet (London, England)
|
September 9, 1989
Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation
A M Gianni, S Siena, M Bregni, et al.
Leukemia Research
|
January 1, 1990
Establishment from an adult leukemic patient of two novel precursor B cell lines with different growth modality
C Tarella, P Pregno, E Gallo, et al.
Bone Marrow Transplantation
|
August 1, 1997
Analysis of the immunoglobulin heavy-chain gene rearrangement providing molecular evidence of second lymphoma in a patient in apparent relapse after autotransplantation
S Campana, P Corradini, M Astolfi, et al.
Bone Marrow Transplantation
|
June 1, 2011
Proposed definition of 'poor mobilizer' in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo ItalianoTrapianto di Midollo Osseo
A Olivieri, M Marchetti, R Lemoli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1995
Haematological support of high-dose sequential chemotherapy: clinical evidence for reduction of toxicity and high response rates in poor risk lymphomas
C Tarella, P Gavarotti, D Caracciolo, et al.
Leukemia & Lymphoma
|
June 28, 2001
Central nervous system relapse in a patient with mantle cell lymphoma in continuous clinical and molecular remission at six years since autografting
M Ladetto, S Sametti, M Astolfi, et al.
Haematologica
|
January 1, 1990
Conditions influencing the expansion of the circulating hemopoietic progenitor cell compartment
C Tarella, D Ferrero, S Siena, et al.
Page
of 9